Cargando…

Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States

OBJECTIVE: Although a high‐resolution computed tomography (HRCT) scan of the chest is the gold standard test for the detection of interstitial lung disease (ILD), there is no consensus among rheumatologists regarding the use of HRCT to screen for ILD in their patients with systemic sclerosis (SSc)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernstein, Elana J., Assassi, Shervin, Castelino, Flavia V., Chung, Lorinda, Correia, Chase, Evnin, Luke B., Frech, Tracy M., Gordon, Jessica K., Skaug, Brian A., Hant, Faye N., Hummers, Laura K., Sandorfi, Nora, Shah, Ami A., Shanmugam, Victoria K., Steen, Virginia D., Khanna, Dinesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274361/ https://www.ncbi.nlm.nih.gov/pubmed/35460213 http://dx.doi.org/10.1002/acr2.11434

Ejemplares similares

Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort
por: Jaafar, Sara, et al.
Publicado: (2021)

Cardiac metabolomics and autopsy in a patient with early diffuse systemic sclerosis presenting with dyspnea: a case report
por: Frech, Tracy M, et al.
Publicado: (2015)

Genetics of scleroderma: implications for personalized medicine?
por: Assassi, Shervin, et al.
Publicado: (2013)

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
por: Rahaghi, Franck F., et al.
Publicado: (2023)

Predicting clinical events using Bayesian multivariate linear mixed models with application to scleroderma
por: Kim, Ji Soo, et al.
Publicado: (2021)

Valuation of scleroderma and psoriatic arthritis health states by the general public
por: Khanna, Dinesh, et al.
Publicado: (2010)

Race and Association With Disease Manifestations and Mortality in Scleroderma: A 20-Year Experience at the Johns Hopkins Scleroderma Center and Review of the Literature
por: Gelber, Allan C., et al.
Publicado: (2013)

Renal Manifestations in Scleroderma: Evidence for Subclinical Renal Disease as a Marker of Vasculopathy
por: Shanmugam, Victoria K., et al.
Publicado: (2010)

Evaluation and management approaches for scleroderma lung disease
por: Schoenfeld, Sara R., et al.
Publicado: (2017)

Autocrine transforming growth factor β signaling regulates extracellular signal-regulated kinase 1/2 phosphorylation via modulation of protein phosphatase 2A expression in scleroderma fibroblasts
por: Samuel, Glady H, et al.
Publicado: (2010)

Review of Current Immunologic Therapies for Hidradenitis Suppurativa
por: Shanmugam, Victoria K., et al.
Publicado: (2017)

Decreased catalytic function with altered sumoylation of DNA topoisomerase I in the nuclei of scleroderma fibroblasts
por: Zhou, Xiaodong, et al.
Publicado: (2011)

Long Term Effects of Cyclophosphamide Treatment on Lung Function and Survival in Scleroderma Patients with Interstitial Lung Disease
por: Mittoo, S, et al.
Publicado: (2011)

Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung Study II (SLS-II), a double-blind, parallel group, randomised controlled trial
por: Tashkin, Donald P, et al.
Publicado: (2016)

HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry
por: Gourh, Pravitt, et al.
Publicado: (2020)

Biomarkers of pulmonary hypertension in patients with scleroderma: a case–control study
por: McMahan, Zsuzsanna, et al.
Publicado: (2015)

Improving outcomes in scleroderma: recent progress of cell-based therapies
por: Khanna, Dinesh, et al.
Publicado: (2022)

Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma
por: Low, Andrea H. L., et al.
Publicado: (2019)

Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database
por: Morgan, Nadia D., et al.
Publicado: (2017)

Association of the HLA-DRB1 with Scleroderma in Chinese Population
por: He, Dongyi, et al.
Publicado: (2014)

Systemic Sclerosis 2011
por: Chung, Lorinda, et al.
Publicado: (2011)

Vascular Disease in Systemic Sclerosis
por: Chung, Lorinda, et al.
Publicado: (2010)

Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts
por: Tsou, Pei-Suen, et al.
Publicado: (2014)

Screening patients with scleroderma for pulmonary arterial hypertension and implications for other at-risk populations
por: Schwaiger, Johannes P., et al.
Publicado: (2013)

47XXY and 47XXX in Scleroderma and Myositis
por: Scofield, R. Hal, et al.
Publicado: (2022)

CD47 prevents the elimination of diseased fibroblasts in scleroderma
por: Lerbs, Tristan, et al.
Publicado: (2020)

Scleroderma with Nodular Scleroderma
por: Srisuttiyakorn, Chutika, et al.
Publicado: (2016)

Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II
por: Volkmann, Elizabeth R., et al.
Publicado: (2020)

Antiphospholipid Antibodies and Systemic Scleroderma
por: Touré, Awa Oumar, et al.
Publicado: (2013)

Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit
por: Kakkar, Vishal, et al.
Publicado: (2022)

Paclitaxel Modulates TGFβ Signaling in Scleroderma Skin Grafts in Immunodeficient Mice
por: Liu, Xialin, et al.
Publicado: (2005)

The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility Trial
por: Carrier, Marie-Eve, et al.
Publicado: (2020)

Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma
por: Tsou, Pei-Suen, et al.
Publicado: (2019)

Scleroderma-related interstitial lung disease
por: Suliman, Sally, et al.
Publicado: (2017)

150 elegantes problemas para futuros matemáticos: con soluciones detalladas /
por: Evnin, Alexandr Yúrievich
Publicado: (2015)

Safety and Tolerability of Thrombin Inhibition in Scleroderma‐Associated Interstitial Lung Disease
por: Silver, R. M., et al.
Publicado: (2019)

Extensive and Persistent Extravascular Dermal Fibrin Deposition Characterizes Systemic Sclerosis
por: Browning, Jeffrey L., et al.
Publicado: (2023)

Scleroderma
Publicado: (1890)

Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma
por: Park, Jong-Sung, et al.
Publicado: (2019)

Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients
por: Wu, Minghua, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9orem4m0fno3icjdtqu8m08osl